Skip to main content
. 2008 Feb 19;34(5):903–906. doi: 10.1007/s00134-008-1020-0

Table 1.

Patient characteristics

Patient Age (years) Sex (male/female) Weight (kg) APACHE II SOFA Creat. start CVVH Diuresis (ml/h) Days CVVH Diagnosis
1 59 M 90 18 12 284 29 9 Cardiac shock with ARDS
2 42 M 100 22 16 287 6 3 Necrotizing fasciitis and ischemic large bowel
3 44 M 85 8 13 124 2,5 6 Abdominal sepsis
4 68 F 56 36 15 367 25 3 Decompensated liver cirrhosis
5 36 F 75 23 8 318 5 3 Fluxus postpartum
6 77 M 75 23 9 131 17 6 Cardiac shock after acute myocardial infarct
7 83 M 75 37 14 180 5 6 Out of hospital cardiac arrest
8 68 M 90 29 14 244 12 10 Septic shock caused by necrotic pancreatitis
9 51 F 70 23 17 422 0 6 Medication induced liver failure
10 72 M 84 27 12 265 31 5 Complicated cardiac surgery
11 56 M 99 25 11 260 25 8 Postoperative after thymectomy
12 66 F 70 20 7 143 67 2 Cardiac and mesenteric ischemia
13 61 M 80 26 13 327 13 4 Intra-abdominal arterial bleeding
14 55 F 74 31 15 243 3 9 Abdominal sepsis caused by fecal peritonitis
15 74 F 65 18 13 84 25 3 Abdominal sepsis caused by ischemia from the small bowel
16 72 M 73 25 11 614 0 3 Respiratory failure caused by fluid overload
17 61 F 58 22 13 162 26 9 Cardiac shock after massive acute myocardial infarct
18 54 M 95 15 12 157 59 6 Respiratory failure caused by pneumonia
19 72 M 80 22 14 136 108 6 Cardiac shock caused by mitral valve insufficiency due to acute myocardial infarct

APACHE II, APACHE II score on the day of admission to ICU; SOFA, SOFA score on day of admission to ICU; Diuresis, urine production (ml/h) in the last 24 h before starting CVVH; Days CVVH, number of days on CVVH at time first blood sample was drawn